How have LLAI shares performed in 2024?

LungLife AI's stock was trading at GBX 46 at the start of the year. Since then, LLAI shares have decreased by 34.8% and is now trading at GBX 30. View the best growth stocks for 2024 here .

How do I buy shares of LungLife AI?

Shares of LLAI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:LLAI

LungLife AI (LLAI) Share Price, News & Analysis

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)

Free LLAI Stock Alerts

GBX 30

-1.00 (-3.23%)

(As of 04/22/2024 09:04 AM ET)

Compare

Today's Range: 30
▼
30
50-Day Range: 28
▼
45.50
52-Week Range: 19
▼
142.10

Volume: 100 shs
Average Volume: 26,359 shs
Market Capitalization: £9.20 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors

Get LungLife AI alerts:

Ad Traders Agency

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

About LungLife AI

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

LLAI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LLAI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive LLAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LungLife AI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: LON:LLAI
CUSIP: N/A
CIK: N/A
Web: lunglifeai.com
Phone: 805 409 9868
Fax: N/A
Employees: 15
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.18)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-5,410,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -51.42%
Return on Assets: -28.69%

Debt

Debt-to-Equity Ratio: 4.37
Current Ratio: 2.28
Quick Ratio: 9.85

Sales & Book Value

Annual Sales: £98,566.00
Price / Sales: 93.32
Cash Flow: GBX 13.17 per share
Price / Cash Flow: 2.28
Book Value: GBX 31 per share
Price / Book: 0.97

Miscellaneous

Outstanding Shares: 30,660,000
Free Float: N/A
Market Cap: £9.20 million
Optionable: Not Optionable
Beta: -0.20

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Dr. Paul Pagano Ph.D. (Age 40)
CEO, Chief Scientific Officer & Executive Director
Comp: $269.17k
Mr. David M. Anderson (Age 61)
CFO, Company Secretary & Executive Director
Comp: $196.1k

Key Competitors

View All Competitors

Insiders

Paul Carmelo Pagano
Bought 12,123 shares on 8/14/2023
Total: £848,610.00 ($70.00/share)

LLAI Stock Analysis - Frequently Asked Questions

How have LLAI shares performed in 2024?: LungLife AI's stock was trading at GBX 46 at the start of the year. Since then, LLAI shares have decreased by 34.8% and is now trading at GBX 30.
View the best growth stocks for 2024 here.
How do I buy shares of LungLife AI?: Shares of LLAI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:LLAI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial